At a glance
ClinicalIndex Comparison RecordPhase 2Completed· 149 enrolled
Drug / intervention
ETX-018810 +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study to Evaluate the Efficacy and Safety of ETX-018810 in Subjects With Lumbosacral Radicular Pain
In Brief
A Phase 2 clinical trial evaluating ETX-018810 and Placebo for Lumbosacral Radiculopathy. Completed, enrolled 149 participants across 24 sites.
Detailed Summary
Efficacy and Safety of ETX 018810 in Subjects with Lumbosacral Radicular Pain
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsLumbosacral Radiculopathy
CountriesUnited States
Collaborators--
Timeline
Phase 2CompletedFinished
202120222023202420252026
Enrollment StartJan 2021
First PostedMar 2021
Primary CompletionMay 2022
Study CompletionMay 2022
TodayJul 2026
First PostedMar 3, 2021
Enrollment StartJan 19, 2021
Primary CompletionMay 16, 2022
Study CompletionMay 25, 2022
TodayJul 2, 2026
Enrollment to primary: 1.3 yearsPosted 5.3 years ago
Interventions
ETX-018810drug
Study Drug
Placebodrug
Placebo